Eliprodil
SIGMA/E2031 - ≥98% (HPLC), powder
Synonym: α-(4-Chlorophenyl)-4-[(4-fluorophenyl)methyl]-1-piperidineethanol; SL 820715
CAS Number: 119431-25-3
Empirical Formula (Hill Notation): C20H23ClFNO
Molecular Weight: 347.85
MDL Number: MFCD00866651
Linear Formula: C20H23ClFNO
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C20H23ClFNO/c21-18-5-3 |
| InChI key | GGUSQTSTQSHJAH-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 200 ![]() |
| SMILES string | OC(CN1CCC(CC1)Cc2ccc(F)cc |
| solubility | DMSO: 5 mg/mL, clear |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | NR2B selective NMDA glutamate receptor antagonist which appears to target the "polyamine site" on the NMDA receptor, setting it apart from other NR2B receptor antagonists. Possesses neuroprotective effects in models of ischemia, but prolongs the QT interval in patients; currently under investigation for acute and chronic pain. |
| Biochem/physiol Actions: | NR2B selective NMDA glutamate receptor antagonist. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

